RocketTickers

Aldeyra Therapeutics Announces Positive Results from Phase 2b

Long
NASDAQ:ALDX   Aldeyra Therapeutics, Inc.
ALDX : Aldeyra Therapeutics, Inc.
2018-09-26 07:00:00
Aldeyra Therapeutics Announces Positive Results from Phase 2b Dry Eye Disease Clinical Trial
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.